72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells

Pathobiology

Volumn 66, Issue 1, 1998, Pages 5-16

  González Avila, Georgina ^a   Iturria, Cecilia ^a   Vadillo, Felipe ^b   Terán, Luis ^a   Selman, Moisés ^a   Pérez Tamayo, Ruy ^c  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Gelatinase A; Gelatinase B; Lung cancer; Matrix metalloproteinases; TIMP 1; TIMP 2

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; LUNG CANCER; LUNG METASTASIS; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

BLOTTING, WESTERN; CARCINOMA, SMALL CELL; COLLAGENASES; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0031935056     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027989     Document Type: Article

References (44)

1. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;4:541-573.
2. Matrisian LM: The matrix degrading metalloproteinases. Bioessays 1992;14:455-463.
3. Woessner JF Jr: The family of matrix metalloproteinases. Ann N Y Acad Sci 1994;732:11-21.
4. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345-1350.
5. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell Docherty A: Regulation of matrix metalloproteinases activity. Ann N Y Acad Sci 1994;732:31-41.
6. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-341.
7. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1994;95:234-245.
8. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ: Metalloproteinases in tumor progression: The contribution of MMP-9. Invasion Metastasis 1994;95:246-258.
9. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dan K, Tryggvason K: Localization of messenger RNA from Mr 72.000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992;52:1336-1341.
10. Davies B, Miles DW, Happerfield LC, Naylor MS, Borbow LG, Rubens RD, Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-1131.
11. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA., Wright PA, Jeffery RE, Longroft JM, Rogers L, Stamp GWH: Stromal expression of 72 kD type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-396.
12. Urbanski SJ, Edwards DR, Mailand A, Leco KJ, Watson A, Kossakowska AE: Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992;66:1188-1194.
13. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hamby A, Balkwill F: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993;53:5365-5369.
14. r 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 1993;53:878-883.
15. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG: Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 1990;136:585-592.
16. Kawahara E, Okada Y, Nakanashi I, Iwata K, Kojima S, Kumagai S, Yamamoto E: The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res 1993;84:409-418.
17. Otani N, Tsukamoto T, Saiki I, Yoneda J, Mitaka T, Kumamoto Y: In vitro invasive potential and type IV collagenolytic activity of human renal cell carcinoma cells derived from primary and metastatic lesions. J Urol 1993;149:1182-1185.
18. Garbisa S, Pozzati R, Muschel R, Saffiotti U, Ballin M, Goldfarb R, Khoury G, Liotta LA: Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res 1987, 1523-1528.
19. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Hams CC, Klein-Szanto AJP: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 1989;49:4615-4621.
20. Ballin M, Gomez D, Sinha C, Thorgeirsson U: Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem Biophys Res Commun 1988;154:832-838.
21. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 1990;50:3872-3877.
22. Canete-Soler R, Litzky L, Lubensky I, Muschel RJ: Localization of the 92 kD gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol 1994;144:518-527.
23. Ginsberg RJ, Kris MG, Armstrong JG: Cancer of the lung; in DeVita, Jr, Hellman S, Rosenberg SA (eds): Cancer The Principles and Practice of Oncology. Philadelphia, Lippincott, 1993. pp 673-758.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-254.
25. Sunada H, Nagai Y: A rapid microassay method for gelatinolytic activity using tritium-labeled heat-denatured polymeric collagen as a substrate and its application to the detection of enzymes involved in collagen metabolism. J Biochem 1980;87:1765-1772.
26. Vadillo-Ortega F, González-Avila G, Furth EE, Hanqin L, Muschel RJ, Stetler-Stevenson WG, Strauss JF III: 92-kD type IV collagenase (matrix metalloproteinase-9) activity in human ammochorion increases with labor. Am J Pathol 1995;146:148-156.
27. Wacher MP, Krutzsch HC, Liotta LA, Stetler-Stevenson W: Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen. J Immunol Methods 1990;126:239-245.
28. 2 synthesis blocks interstitial collagenase and 92-kDa Type IV collagenase/gelatinase production by human monocytes. J Biol Chem 1992;267:515-519.
29. Kleiner DE, Unsworth EJ, Krutzsch HC, Stetler-Stevenson WG: Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 1992;31:1665-1672.
30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 1970;227:680-684.
31. Momiki S, Baba M, Caamano J, Iizasa T, Nakajima M, Yamaguchi Y, Klein-Szanto A: In vivo and in vitro invasiveness of human lung carcinoma cell lines. Invasion Metastasis 1991;11:66-75.
32. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto AJP: Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revenant cell lines: Not an invariant correlation with metastasis. Int J Cancer 1992;52:366-371.
33. Brown PD, Blowidge RE, Stuart NSA, Gatter KC, Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer lost 1993;85:574-578.
34. Lala PK, Graham CH: Mechanisms of trophoblast invasiveness and their control. The role of proteases and protease inhibitors. Cancer Metastasis Rev 1990;9:369-379.
35. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Guidice LC, Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. J Obstet Gynecol 1993;168:253-260.
36. Alexander CM, Werb Z: Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol 1992;118:727-739.
37. Schults RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B-16-F10 melanoma cells. Cancer Res 1988;48:5539-5545.
38. De Clerk YA, Yean TD, Chan D, Shimada H, Langley KE: Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteraase inhibitor. Cancer Res 1991;51:2151-2157.
39. Ponton A, Coulombe B, Skup D: Decreased expression of tissue inhibitor of metalloproteinases in metastasic tumor cells leading to increased levels of collagenase activity. Cancer Res 1991;51:2138-2143.
40. Testa JE: Loss of the metastasic phenotype by a human epidermoid carcinoma cell line, Hep-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res 1992;52:5597-5603.
41. Lu S, Levy MI, Weinstein B, Santella RM: Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res 1991;51:6231-6235.
42. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Selki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-65.
43. Strogin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 1995;270:5331-5338.
44. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG: Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int 1993;43:163-170.